help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 22, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-1209
A more recent version of this article appeared on June 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/6/3268    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berggren, A.
Right arrow Articles by Caidahl, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berggren, A.
Right arrow Articles by Caidahl, K.

Submitted on June 24, 2004
Accepted on March 15, 2005

Short-Term administration of supraphysiologic rhGH does not increase maximum endurance exercise capacity in healthy, active young men and women with normal GH-IGF-1 axes

Annika Berggren M.D., Christer Ehrnborg M.D., Thord Rosén M.D., Ph.D., Lars Ellegård M.D. Ph.D., Bengt-Åke Bengtsson M.D. Ph.D., and Kenneth Caidahl M.D., Ph.D.*

Departments of Clinical Physiology, Endocrinologyand Clinical Nutrition, Sahlgrenska University Hospital, Göteborg; Karolinska Institute, Stockholm; Sweden

* To whom correspondence should be addressed. E-mail: kencai{at}ki.se.

Context. In spite of the fact that the use of growth hormone (GH) as a doping agent in sports is widespread, little is known about its short-term effects.

Objective. To study the effects of GH on exercise capacity.

Design. Double-blind, placebo-controlled study; treatment period 28 days.

Setting. Subjects from general community studied ambulatory at a university hospital.

Participants. 30 healthy active young normal volunteers, 15 female and 15 male, were recruited by local announcement and all completed the study.

Intervention. All the subjects were randomized to receive a low GH dose (0.033 mg, or 0.1 IU, per kg/day), a high GH dose (0.067 mg, or 0.2 IU, per kg/day) or placebo.

Main outcome measures. Power output and oxygen uptake (VO2) on bicycle exercise.

Results. We found no effect by the low or high dosages of GH on maximum oxygen uptake during exercise (mean ± SE for placebo 45.2 ± 1.6 to 45.2 ± 2.1ml/kg/min, GH low dose 42.8 ± 1.6 to 42.8 ± 1.6 ml/kg/min and GH high dose 44.8 ± 3.4 to 44.8 ± 2.2 ml/kg/min; two-way ANOVA not significant). Neither was there any effect on maximum achieved power output during exercise, nor on blood pressure, heart rate or the electrocardiographic ST-level at rest or during exercise. GH significantly increased total body weight (P = 0.028), an effect predominantly ascribed to fluid retention (increased extracellular water volume, ECW), while muscle mass (as indicated by intracellular water volume, ICW) did not change. However, changes of the latter correlated to changes in physical performance, possibly due to different training efforts.

Conclusion. Supraphysiologic rhGH during a period of 4 weeks does not improve power output or oxygen uptake.


Key words: Doping • exercise capacity • growth hormone • intracellular water • oxygen uptake




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
H. Liu, D. M. Bravata, I. Olkin, A. Friedlander, V. Liu, B. Roberts, E. Bendavid, O. Saynina, S. R. Salpeter, A. M. Garber, et al.
Systematic Review: The Effects of Growth Hormone on Athletic Performance
Ann Intern Med, May 20, 2008; 148(10): 747 - 758.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Gibney, M.-L. Healy, and P. H. Sonksen
The Growth Hormone/Insulin-Like Growth Factor-I Axis in Exercise and Sport
Endocr. Rev., October 1, 2007; 28(6): 603 - 624.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
J. Young, A. Anwar, and C. Milne
Strong diabetes * COMMENTARY
Br. J. Sports Med., May 1, 2007; 41(5): 335 - 336.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. L. Healy, J. Gibney, C. Pentecost, P. Croos, D. L. Russell-Jones, P. H. Sonksen, and A. M. Umpleby
Effects of High-Dose Growth Hormone on Glucose and Glycerol Metabolism at Rest and during Exercise in Endurance-Trained Athletes
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 320 - 327.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society